Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation
The Journal of Dermatology · 16.08.2026
DOI: 10.1111/1346-8138.70470 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 16.08.2026. Verfasst von Masahiro Iwata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Hospital Organization Mito Medical Center, Ibaraki, Japan. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
- Department of Dermatology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
- Allergy Center, University of Tsukuba Hospital, Ibaraki, Japan.
ORCID-Profile: Masahiro Iwata, Tatsuya Ogawa
Zitieren
APA
Iwata, M., & Ogawa, T. (2026). Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70470
Vancouver
Iwata M, Ogawa T. Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70470
BibTeX
@article{Iwata2026,
author = {Iwata, Masahiro and Ogawa, Tatsuya},
title = {Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation},
journal = {The Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70470}
}
EUVIMED